It is known that the action of sorafenib on liver cancer cells can induce robust expression of p53-upregulated-modulator-of-apoptosis (PUMA) [36], the expression level of which in our experiments was many times higher when SeNPs and SeSo were used. Here, BBC3 is linked to liver cancer.